Introduction

Ca
2+ /calmodulin-dependent protein phosphatase calcineurin, a protein phosphatase type 2B, is one of four principal types of serine/threonine-specific protein phosphatases present in mammalian tissues (Cohen 1989) . Although it was originally discovered as a neural tissue-enriched calmodulin-binding protein (Klee & Krinks 1978; Wang & Desai 1977) , calcineurin is broadly distributed in other tissues, and highly conserved from yeast to man. The phosphatase is a heterodimer of the catalytic (calcineurin A) and the regulatory (calcineurin B) subunits (Klee et al. 1979) .
Two important immunosuppressive drugs, tacrolimus (FK506) and cyclosporin A (CsA), are potent and specific inhibitors of calcineurin phosphatase activity (Liu et al. 1991) . These drugs have been widely used to prevent graft rejection after organ and tissue transplantations.
The use of these drugs has revealed the role of calcineurin in various cellular processes, including lymphocyte activation, cardiac development and hypertrophy, learning and memory, and angiogenesis (Aramburu et al. 2000; Sugiura et al. 2001) .
The regulation of gene expression in response to Ca 2+ stimuli is one of the most explored functions of calcineurin. Importantly, the critical target of calcineurin is the NF-AT family of transcription factors, during T-cell activation (Crabtree & Clipstone 1994) . In resting cells, NF-AT proteins are phosphorylated and are retained in the cytoplasm. Upon binding of antigen to T-cell receptor, intracellular Ca 2+ is elevated through the action of protein tyrosine kinases and phospholipase C. Calcineurin is then activated through binding of Ca 2+ /CaM and dephosphorylates the cytosolic forms of the NF-AT proteins (O'Keefe et al. 1992) , which are co-transported with calcineurin to the nucleus , where either alone or in co-operation with AP-1 family members bind with specific cis elements in the *Correspondence: E-mail: tkuno@med.kobe-u.ac.jp promoter/enhancer regions of cytokine genes, such as IL-2. The immunosuppressants CsA and FK506 bind to inhibit calcineurin, thereby preventing the dephosphorylation, nuclear translocation and the activation of NF-AT, thus leading to the suppression of T-cell receptoractivated signal transduction pathway by CsA and FK506 (Liu et al. 1991) .
Calcineurin is also involved in cardiac hypertrophy in mice. Cardiac hypertrophy is induced by calcineurin, which dephosphorylates the transcription factor NF-AT3, enabling it to translocate to the nucleus. NF-AT3 interacts with the cardiac zinc finger transcription factor GATA-4, resulting in the synergistic activation of cardiac transcription (Molkentin et al. 1998) . The immunosuppressants block this hypertrophy in vivo and in vitro (Sussman et al. 1998) , indicating that calcineurin also controls muscle hypertrophy by regulating a signalling that is very similar to that of T-cell activation pathway as described above. Thus, calcineurin regulates the activity of NF-AT transcription factors primarily through regulating their localization in mammalian tissues.
In budding yeast, calcineurin dephosphorylates CRZ1/ TCN1, a zinc-finger type transcription factor, resulting in the translocation of CRZ1 to the nucleus, thereby regulating the expression of PMC1, PMR1, PMR2A and FKS2 (Stathopoulos & Cyert 1997; Matheos et al. 1997) . A region of CRZ1 that is required for calcineurindependent regulation has a significant sequence similarity to a portion of NF-AT. These results suggest an evolutionarily conserved mechanism by which calcineurin regulates gene expression by controlling the phosphorylation state and the localization of transcription factors in response to Ca 2+ mobilizing stimuli. Although transcription factors are important calcineurin targets, calcineurin has also been reported to regulate various physiological functions by dephosphorylating cytoplasmic functional proteins. These include a role in apoptosis, in intracellular trafficking and in the migration of neutrophils on fibronectin in response to Ca 2+ (Aramburu et al. 2000) . However, the physiological substrates of calcineurin that regulate these processes are not known and most of the mechanisms underlying these roles still remain obscure.
Fission yeast as a model system to study calcineurin signalling pathway
Functional homologues of calcineurin have been reported in fission yeast. Recent genome projects revealed that the fission yeast S. pombe sequence encodes 4824 proteins, whereas the budding yeast S. cerevisiae genome encodes about 6500 proteins (Wood et al. 2002) . Also, in fission yeast, only one gene, ppb1 + , has been identified to encode calcineurin catalytic A subunit (Yoshida et al. 1994) , whereas there are two genes in budding yeast namely CNA1/CMP1 and CNA2/ CMP2 that encode for calcineurin A (Liu et al. 1991; Cyert et al. 1991) . Fission yeast and budding yeast each contain one gene that encodes calcineurin regulatory B subunit (Kuno et al. 1991; Cyert & Thorner 1992) .
Having the smallest number of protein-coding genes amongst eukaryotes, with relevance to higher eukaryotic systems, and together with the powerful and sophisticated genetics available, S. pombe is an excellent model organism with which to analyse complex signalling pathways regulated by calcineurin. Due to the evolutionary conservation, the calcineurin signalling in this model system may be translatable to higher eukaryotes.
Genetic analysis of calcineurin function
The identification and characterization of calcineurin in fission yeast made possible an extensive genetic dissection of calcineurin function. Examination of calcineurin knockout mutants identified multiple and essential functions for this protein in vivo as described below. Also, new gene products identified from a genetic screen for multicopy suppressors of calcineurin deletion demonstrated a cross-talk between MAP kinase and calcineurin signalling pathways as described later (see also Fig. 1 and Table 1 ). Furthermore, based on a genetic screen using the immunosuppressive drug FK506, new gene products that closely function in calcineurin signalling were identified as described in this paper (see also Table 1 ).
Analysis of the calcineurin knockout mutant
Gene disruption experiments have demonstrated that ppb1 null cells of S. pombe were viable under optimal growth conditions. Although viable, calcineurin deletion displayed grossly abnormal morphology. The ppb1 null cells showed greatly delayed cytokinesis and a large number of cells were multiseptated, which were never observed in wild-type cells (Yoshida et al. 1994) . The cell polarity control was also impaired, causing branched cells. This demonstrates the essential role of fission yeast calcineurin in cytokinesis and morphology. In clear contrast to calcineurin null cells in fission yeast, budding yeast calcineurin knockout displays no dramatic morphological change under optimal growth conditions. Thus, fission yeast provides an excellent model system to analyse calcineurin function in cell morphology and cytokinesis.
Further genetic analysis established that calcineurin is also essential for Cl -homeostasis. Fission yeast calcineurin deletion confers a drastic hypersensitivity to Cl - (Sugiura et al. 1998) . In budding yeast, null mutants lacking the calcineurin gene exhibit a salt-hypersensitive phenotype, but their sensitivity is dependent on cations such as Na + or Li + (Nakamura et al. 1993; Mendoza et al. 1994) . The LiCl sensitivity of the ppb1 null cells was compared with that of wild-type cells, but no marked difference was observed (our unpublished results). Thus, budding and fission yeasts show greatly different sensitivities to ions in the calcineurin null mutants. Intriguingly, the cytokinesis defects of calcineurin deletion is further enhanced in the presence of low concentrations of Cl -, wherein wild-type cells grow normally (our unpublished results).
Moreover, a recent genetic approach has identified the second Type II myosin heavy chain, Myo3/Myp2/ Cis2 as a component, which closely functions in the calcineurin-mediated pathway. Interestingly, myo3/myp2/ cis2 mutation showed severe sensitivity to Cl -and cytokinesis defects, very similar to calcineurin deletion. In addition, expression of constitutively active and Ca 2+ -independent form of calcineurin suppressed the defective phenotypes of mutation and deletion of myo2/myp3/cis2 gene (Fujita et al. 2002) .
Thus, these two functions executed by fission yeast calcineurin, namely the maintenance of Cl -ion homeostasis and cytokinesis, may be mutually related. In mammalian cells, contractile activity-dependent expression of slow myosin heavy chain is mediated largely through the calcineurin-mediated NF-AT pathway (Chin et al. 1998) . In this context, it would be interesting to speculate that calcineurin may regulate the expression of type II myosin, through direct or indirect dephosphorylation, thereby affecting cytokinesis in fission yeast.
Cross-talk with the MAP kinase signalling pathway
The phosphorylation state of proteins is controlled by opposing kinase and phosphatase activities. Thus, the understanding of reversible phosphorylation in which the opposing kinase counteracts calcineurin phosphatase actions is essential for elucidating calcineurin-mediated signalling pathway.
Interestingly, a genetic approach has demonstrated the cross-talk between the MAP kinase pathway and calcineurin phosphatase in fission yeast. This is based on a genetic screen aiming to identify genes that functionally interact with calcineurin through isolation of multicopy plasmids that suppress the Cl --sensitive growth defect of ppb1 deletion.
A novel gene pmp1 + (S. pombe MAP kinase phosphatase 1), which encodes a member of the dualspecificity MAP kinase phosphatases suppresses the Calcineurin specifically dephosphorylates Elk-1, and negatively regulates its transcriptional activity. The calcineurindependent activation and nuclear import of NFAT is also regulated by the opposing NFAT kinases. S. cerevisiae: Calcineurin dephosphorylates Crz1/TCN1, a zinc-finger type transcription factor, resulting in the translocation of Crz1 to the nucleus, thereby regulating the expression of PMC1, PMR1, PMR2A and FKS2. (Sugiura et al. 1998) . Consistently, the loss of the Pmk1 MAP kinase function (deletion of the pmk1 + gene), or the loss of the mkh1 + gene (Sengar et al. 1997) , which encodes a MAP kinase kinase kinase for the Pmk1/Spm1 MAP kinase Zaitsevskaya-Carter & Cooper 1997) , also suppressed the Cl -sensitivity of calcineurin deletion. These data clearly indicate that calcineurin phosphatase and the Pmk1 MAP kinase pathway play antagonistic roles in Cl -homeostasis (Fig. 1) . Furthermore, the PKC pathway may also have an opposing role to the calcineurin signalling pathway in Cl -homeostasis because the loss of pck2 + , encoding a PKC-like protein (Toda et al. 1993) , also suppressed the Cl --sensitive growth defect when combined with ppb1 deletion (Sugiura et al. 1998) . These results suggest the existence of a cross-talk between calcineurin and the signalling pathways regulated by the Pmk1 MAP kinase or the Pck2 kinase.
In addition to pmp1 + , a novel gene pek1 + (S. pombe MEK 1), which encodes a MAPKK suppresses the Cl --sensitive growth defect accompanying calcineurin deletion (Sugiura et al. 1999) . Surprisingly, subsequent genetic and biochemical analyses have established that Pek1 is the MAP kinase kinase (MAPKK) for Pmk1, indicating that the negative regulator (MAP kinase phosphatase; Pmp1) and the activating regulator (MAPKK; Pek1) for the same MAPK (Pmk1) were isolated in the same genetic screen. We have solved this contradiction by demonstrating that unphosphorylated Pek1 has a potent inhibitory effect on Pmk1 kinase activity, thereby suppressing calcineurin deletion (Sugiura et al. 1999) .
Although the molecular targets and the biochemical mechanism for the functional interaction involving calcineurin is yet to be identified, it is possible that calcineurin dephosphorylates a MAPK substrate involved in the regulation of Cl -ion transport. In the absence of calcineurin, the substrate accumulates in its phosphorylated state, which prevents Cl -export. One way to reverse this effect is to inhibit the activity of the MAPK responsible for the phosphorylation event. Thus, calcineurin and the Pmp1 phosphatase are both implicated in the down-regulation of the MAP kinase signalling, thereby playing synergistic roles in Cl -homeostasis (Fig. 1) .
Recently, several lines of evidence have suggested the existence of a cross-talk between the calcineurin and MAP kinase signalling pathways, both in higher and lower eukaryotes. Transcription factors such as Elk-1, which belongs to the ETS and ternary complex factor (TCF) families, has been reported to be modulated by calcineurin (Sugimoto et al. 1997) . Stimulation of Elk-1 transcriptional activity by phosphorylation is mediated by diverse MAP kinases (ERK-1/ERK-2, JNK and p38 MAPKs) (Tian & Karin 1999) . Calcineurin specifically dephosphorylates Elk-1, and negatively regulates its transcriptional activity (Fig. 1) , thus identifying calcineurin as a physiologically relevant Elk-1 phosphatase. This finding links calcineurin to a ubiquitous sequencespecific transcription factor, Elk-1, which serves as a target for all three MAP kinase pathways and plays an important role in the induction of immediate-early gene transcription.
As described above, the best characterized targets of calcineurin are the members of the NF-AT family. Importantly, this calcineurin-dependent activation and nuclear import of NF-AT is also regulated by the opposing NF-AT kinases. There are several candidates for the NF-AT kinase, although the identity of the kinases that oppose calcineurin action remains controversial. Glycogen Synthase kinase-3 (Beals et al. 1997) , Casein kinase 1 (Zhu et al. 1998) , Jun N-terminal Kinase ( JNK) (Chow et al. 1997) , MEKK1 (Zhu et al. 1998 ) and p38 MAPK (Porter et al. 2000) have been reported to play a role in the nuclear shuttling of NF-AT, thereby counteracting calcineurin activities.
There is a striking similarity in the cross-talk between calcineurin and the MAP kinase signalling as seen in mammals and in S. pombe. By way of comparison, the cross-talk between calcineurin and the Pmk1 MAP kinase pathway in fission yeast can be explained by the hypothesis that calcineurin phosphatase dephosphorylates a Pmk1 MAPK substrate, possibly a transcription factor (marked ?, in Fig. 1) , involved in the regulation of Cl -transport. In contrast to fission yeast and mammals, calcineurin and the MPK1 MAP kinase appear to function synergistically in budding yeast (Fig. 1) . Loss-of-function mutations in calcineurin and protein kinase C-MPK1 MAP kinase caused a synthetic lethal phenotype, and defective phenotypes associated with protein kinase C-MPK1 MAP kinase pathway were suppressed by the expression of a constitutively active form of calcineurin (Nakamura et al. 1996; Garrett et al. 1995) . Consistent with this, calcineurin and the MPK1 MAP kinase synergistically regulate SWE1 activation at the transcriptional and post-translational levels, respectively, and both are required for the calcium-induced delay in G2 phase (Mizunuma et al. 1998) . Thus, although both calcineurin and MAPKs are evolutionarily conserved, a synergistic relationship between calcineurin and MAP kinase pathway, and a role of calcineurin in cell cycle control as seen in budding yeast may not be applicable to other organisms. This indicates a highly significant difference between fission and budding yeast that could be pertinent to the understanding of the physiological role of calcineurin.
Genetic analysis of the functionally-related genes interacting with calcineurin
Calcineurin is an in vivo target of FK506 in fission yeast, and inhibition of calcineurin activity by gene disruption or by the addition of FK506 to the media does not affect the vegetative growth of fission yeast. This suggests that other regulatory pathways in the cell exist, and that they perform overlapping functions with calcineurin. Thus, such mutants, which require calcineurin activity for vegetative growth, would not grow in the presence of FK506.
A genetic screen to search for the mutations that show sensitivity to the immunosuppressive drug FK506 has been performed, and eight complementation groups (its1-8 for immunosuppressant-and temperaturesensitive) were identified (Zhang et al. 2000; Yada et al. 2001) . The gene products encoded by its genes are listed in Table 1 . Interestingly, these gene products are highly conserved, except for Its2 (glucan synthase), suggesting that the molecular mechanisms underlying the functional interactions between calcineurin and these gene products in the signal transduction pathway might be conserved through evolution.
PI(4)P5K (Its3): PI turnover its3
+ encodes a protein most similar to the budding yeast Mss4 phosphatidylinositol 4-phosphate 5-kinase (PI(4)P5K) (Desrivieres et al. 1998; Homma et al. 1998) and murine PI(4)P5K (Ishihara et al. 1996) , which catalyse the production of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). PI(4,5)P2 serves as a precursor for diacylglycerol and inositol trisphosphate in signal transduction cascades, which are involved in the activation of protein kinase C and the release of intracellular stored calcium. Biochemical characterization of the Its3 gene product has revealed that it encodes a functional homologue of PI(4)P5K (Zhang et al. 2000) .
its3-1 mutant cells also displayed abnormality in cytokinesis, because the shift to the restrictive temperature or the addition of FK506 to the culture media dramatically increased the septation index of its3-1 mutant cells. Furthermore, in its3-1 mutant cells, actin patches were completely disorganized upon temperature upshift or FK506 treatment. These results together with the synthetic lethal interaction between calcineurin and Its3 mutation suggest a functional link between calcineurin and PI-turnover involved in cytokinesis and actin organization.
It is noteworthy that GFP (green fluorescent protein)-tagged Its3 proteins and the PLC (phospholipase C) delta PH (pleckstrin homology)-domain indicated plasma membrane localization of PI(4)P5K and PI(4,5)P2. These proteins were also concentrated at the septum of dividing cells, consistent with its role in septation. Surprisingly, the mutant Its3 protein was no longer localized to the plasma membrane, suggesting that the plasma membrane localization of Its3 is crucial in controlling the production of PI(4,5)P2 at the correct place to tightly regulate the actin cytoskeleton organization and/ or cytokinesis (Zhang et al. 2000) .
PI(4,5)P2 has been shown to bind to a number of proteins that bind actin and/or regulate the actin cytoskeleton, including cofilin and profilin. Interestingly, the small GTPases of the Rho family, RhoA, Cdc42 and Rac1, which are involved in the regulation of the actin cytoskeleton, are physically and functionally associated with PI-kinases (Carpenter et al. 1999) . ARF6, another small GTPase, triggers the recruitment of PI 5-kinase into membrane ruffles, leading to elevated PI(4,5)P2 concentration in these sites of active cytoskeletal rearrangements (Honda et al. 1999) . These data illustrate the general importance of local PI dynamics at the plasma membrane cytoskeleton interface in higher systems and in S. pombe.
Recently, it has been reported that PI(4)P5K in fission yeast is a target of Cki1 (Vancurova et al. 1999) , encoding a homologueue of casein kinase I, and that Cki1 regulates PI(4,5)P2 synthesis by phosphorylating and inactivating PI (4)P5K. In this context, it would be interesting to speculate that calcineurin may directly or indirectly activate Its3 PI(4)P5K through dephosphorylation.
Beta adaptin (Its1), Rab family (Its5/Ypt3): membrane transport
The functions of calcineurin have been shown to regulate vesicle transport in higher eukaryotic systems, and to dephosphorylate several proteins required for clathrin-mediated vesicle recycling such as dynamin, amphiphysin and synaptojanin, thus suggesting a potential role for calcineurin-dependent dephosphorylation in regulating synaptic vesicle endocytosis (Marks & McMahon 1998) . However, in lower eukaryotic systems such as budding yeast no such findings have been reported on the role of calcineurin in the vesicle transport or exocytic pathway.
In contrast, the key players of membrane traffic in fission yeast have begun to be identified, based on the genetic screen using the immunosuppressive drug FK506. These include the its1 + gene, which encodes a homologue of the mammalian beta subunit of clathrin AP-2 complex (C. Sakamoto, R. Sugiura, K. Takegawa, Y. Lu, T. Kuno & H. Shuntoh, unpublished result) Moreover, its5-1 mutant cells also showed defects in cytokinesis, vacuole fusion, as well as in cell wall integrity, and displayed the accumulation of abnormal Golgi and secretory vesicles. Furthermore, these abnormal phenotypes were accentuated at high temperature or by FK506-treatment, suggesting a connection of Its5/ Ypt3-mediated exocytic pathway to calcineurin function.
This raises the intriguing hypothesis that these proteins and calcineurin synergistically regulate membrane transport; alternatively, calcineurin affects the defective phenotypes of these mutant cells through the regulation of cell wall integrity, which might explain the synthetic lethal interaction. Thus, elucidation of the mechanisms of interaction between calcineurin and these proteins may be of general interest for an understanding of the eukaryotic transport system and/or morphogenetic events.
Conclusion
In this review, we have highlighted the importance of calcineurin in signal transduction, as well as the complex molecular network in which fission yeast calcineurin is involved. From genetic analyses, together with the use of calcineurin inhibitor FK506, it is clear that the calcineurin-mediated signalling pathways execute crucial roles in a variety of aspects in fission yeast. These roles include cytokinesis, cell polarity control, Cl -homeostasis, cytoskeletal regulation, membrane traffic and cell wall metabolism. Although recent advances described in this review have begun to uncover molecular networks that genetically and functionally interact with the calcineurin pathway, such as the MAPK cascade and the PI signalling, it remains to be elucidated how these pathways are co-ordinated with each other. The fission yeast system will no doubt continue to provide valuable information on the physiological function of calcineurin.
